Skip to main content

Advertisement

SpringerLink
Log in

Epigenetic tumor suppression by BRCA1

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

BRCA1 germline mutations lead to an increased risk of breast and ovarian cancer, but the mechanisms by which the product of this gene functions as a tumor suppressor have remained elusive. Now, analysis of a missense BRCA1 variant shows that it can epigenetically regulate an miRNA implicated in cancer, providing new mechanistic insights (pages 1275–1282).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: BRCA1 can act as a tumor suppressor by epigenetically regulating the expression of the oncogenic miRNA-155.

References

  1. Ford, D. et al. Am. J. Hum. Genet. 62, 676–689 (1998).

    Article  CAS  Google Scholar 

  2. Narod, S.A. & Foulkes, W.D. Nat. Rev. Cancer 4, 665–676 (2004).

    Article  CAS  Google Scholar 

  3. Atchley, D.P. et al. J. Clin. Oncol. 26, 4282–4288 (2008).

    Article  Google Scholar 

  4. Lee, M.S. et al. Cancer Res. 70, 4880–4890 (2010).

    Article  CAS  Google Scholar 

  5. Morris, J.R. et al. Hum. Mol. Genet. 15, 599–606 (2006).

    Article  CAS  Google Scholar 

  6. Chang, S., Biswas, K., Martin, B.K., Stauffer, S. & Sharan, S.K. J. Clin. Invest. 119, 3160–3171 (2009).

    Article  CAS  Google Scholar 

  7. Chang, S. et al. Nat. Med. 17, 1275–1282 (2011).

    Article  CAS  Google Scholar 

  8. Lovelock, P.K. et al. Breast Cancer Res. 9, R82 (2007).

    Article  Google Scholar 

  9. O'Connell, R.M. et al. J. Exp. Med. 205, 585–594 (2008).

    Article  CAS  Google Scholar 

  10. Costinean, S. et al. Blood 114, 1374–1382 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aneliya Velkova and Alvaro N.A. Monteiro are at the Cancer Epidemiology Program at H. Lee Moffitt Cancer Center, Tampa, Florida, USA.,

    Aneliya Velkova & Alvaro N A Monteiro

Authors
  1. Aneliya Velkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alvaro N A Monteiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alvaro N A Monteiro.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Velkova, A., Monteiro, A. Epigenetic tumor suppression by BRCA1. Nat Med 17, 1183–1185 (2011). https://doi.org/10.1038/nm.2493

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2493

  • Springer Nature America, Inc.

Search

Navigation